Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 8 May 1992:
Vol. 256. no. 5058, pp. 789 - 794
DOI: 10.1126/science.256.5058.789

Articles

Science, Vol 256, Issue 5058, 789-794
Copyright © 1992 by American Association for the Advancement of Science


articles

Malignant hyperthermia

DH MacLennan and MS Phillips

Banting & Best Department of Medical Research, University of Toronto, Ontario, Canada.

In humans genetically predisposed to malignant hyperthermia, anesthesia can induce skeletal muscle rigidity, hypermetabolism, and high fever, which, if not immediately reversed, can lead to tissue damage or death. The corresponding condition in swine leads to stress-induced deaths and devalued meat products. Abnormalities in the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (the ryanodine receptor) have been implicated in the cause of both the porcine and human syndromes by physiological and biochemical studies and genetic linkage analysis. In swine, a single founder mutation in the ryanodine receptor gene (RYR1) can account for all cases of malignant hyperthermia in all breeds, but a series of different RYR1 mutations are likely to be uncovered in human families with MH. Moreover, lack of linkage between malignant hyperthermia and RYR1 in some families indicates a heterogeneous genetic basis for the human syndrome.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Pale poultry muscle syndrome.
D. P. Smith and J. K. Northcutt (2009)
Poult. Sci. 88, 1493-1496
   Abstract »    Full Text »    PDF »
A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.
Z. Andronache, S. L. Hamilton, R. T. Dirksen, and W. Melzer (2009)
PNAS 106, 4531-4536
   Abstract »    Full Text »    PDF »
Inactivation of UCP1 and the Glycerol Phosphate Cycle Synergistically Increases Energy Expenditure to Resist Diet-induced Obesity.
R. Anunciado-Koza, J. Ukropec, R. A. Koza, and L. P. Kozak (2008)
J. Biol. Chem. 283, 27688-27697
   Abstract »    Full Text »    PDF »
Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia.
D. Jiang, W. Chen, J. Xiao, R. Wang, H. Kong, P. P. Jones, L. Zhang, B. Fruen, and S. R. W. Chen (2008)
J. Biol. Chem. 283, 20813-20820
   Abstract »    Full Text »    PDF »
Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease.
H. Hirata, T. Watanabe, J. Hatakeyama, S. M. Sprague, L. Saint-Amant, A. Nagashima, W. W. Cui, W. Zhou, and J. Y. Kuwada (2007)
Development 134, 2771-2781
   Abstract »    Full Text »    PDF »
Malignant Hyperthermia Following Systemic Rewarming After Hypothermic Cardiopulmonary Bypass.
A. D. Lichtman and C. Oribabor (2006)
Anesth. Analg. 102, 372-375
   Abstract »    Full Text »    PDF »
Malignant hyperthermia.
K. G. Allman and l. H. Wilson (2006)
Oxford Handbook of Anaesthesia 2, med-9780198566090-div1-10
   Full Text »
3,4-Methylenedioxymethamphetamine (Ecstasy) Activates Skeletal Muscle Nicotinic Acetylcholine Receptors.
W. Klingler, J. J. A. Heffron, K. Jurkat-Rott, G. O'Sullivan, A. Alt, F. Schlesinger, J. Bufler, and F. Lehmann-Horn (2005)
J. Pharmacol. Exp. Ther. 314, 1267-1273
   Abstract »    Full Text »    PDF »
Ca2+ Signaling in HEK-293 and Skeletal Muscle Cells Expressing Recombinant Ryanodine Receptors Harboring Malignant Hyperthermia and Central Core Disease Mutations.
M. Brini, S. Manni, N. Pierobon, G. G. Du, P. Sharma, D. H. MacLennan, and E. Carafoli (2005)
J. Biol. Chem. 280, 15380-15389
   Abstract »    Full Text »    PDF »
Effect of Ryanodine Receptor Mutations on Interleukin-6 Release and Intracellular Calcium Homeostasis in Human Myotubes from Malignant Hyperthermia-susceptible Individuals and Patients Affected by Central Core Disease.
S. Ducreux, F. Zorzato, C. Muller, C. Sewry, F. Muntoni, R. Quinlivan, G. Restagno, T. Girard, and S. Treves (2004)
J. Biol. Chem. 279, 43838-43846
   Abstract »    Full Text »    PDF »
Scanning for Mutations of the Ryanodine Receptor (RYR1) Gene by Denaturing HPLC: Detection of Three Novel Malignant Hyperthermia Alleles.
A. Tammaro, A. Bracco, S. Cozzolino, M. Esposito, A. Di Martino, G. Savoia, L. Zeuli, G. Piluso, S. Aurino, and V. Nigro (2003)
Clin. Chem. 49, 761-768
   Abstract »    Full Text »    PDF »
Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor.
F. Zorzato, N. Yamaguchi, L. Xu, G. Meissner, C. R. Muller, P. Pouliquin, F. Muntoni, C. Sewry, T. Girard, and S. Treves (2003)
Hum. Mol. Genet. 12, 379-388
   Abstract »    Full Text »    PDF »
Extending the Skeletal Muscle Viability Period in the Malignant Hyperthermia Test.
S. Bina, S. Holman, and S. M. Muldoon (2003)
Anesth. Analg. 96, 153-158
   Abstract »    Full Text »    PDF »
Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells.
T. Girard, S. Treves, K. Censier, C. R. Mueller, F. Zorzato, and A. Urwyler (2002)
Br. J. Anaesth. 89, 571-579
   Abstract »    Full Text »    PDF »
B-lymphocytes from Malignant Hyperthermia-susceptible Patients Have an Increased Sensitivity to Skeletal Muscle Ryanodine Receptor Activators.
T. Girard, D. Cavagna, E. Padovan, G. Spagnoli, A. Urwyler, F. Zorzato, and S. Treves (2001)
J. Biol. Chem. 276, 48077-48082
   Abstract »    Full Text »    PDF »
Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
N. Tilgen, F. Zorzato, B. Halliger-Keller, F. Muntoni, C. Sewry, L. M. Palmucci, C. Schneider, E. Hauser, F. Lehmann-Horn, C. R. Muller, et al. (2001)
Hum. Mol. Genet. 10, 2879-2887
   Abstract »    Full Text »    PDF »
Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor.
G. Avila, J. J. O'Brien, and R. T. Dirksen (2001)
PNAS 98, 4215-4220
   Abstract »    Full Text »    PDF »
Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.
B Dietze, J Henke, H M Eichinger, F Lehmann-Horn, and W Melzer (2000)
J. Physiol. 526, 507-514
   Abstract »    Full Text »    PDF »
Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease.
M. W. Berchtold, H. Brinkmeier, and M. Muntener (2000)
Physiol Rev 80, 1215-1265
   Abstract »    Full Text »    PDF »
A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
R. L. Brown, A. N. Pollock, K. G. Couchman, M. Hodges, D. O. Hutchinson, R. Waaka, P. Lynch, T. V. McCarthy, and K. M. Stowell (2000)
Hum. Mol. Genet. 9, 1515-1524
   Abstract »    Full Text »    PDF »
Contribution of Autosomal Loci and the Y Chromosome to the Stress Response in Rats.
P. Dumas, Z. Pausova, V. Kren, D. Krenova, M. Pravenec, M. Dumont, D. Ely, M. Turner, Y. Sun, J. Tremblay, et al. (2000)
Hypertension 35, 568-573
   Abstract »    Full Text »    PDF »
A Multicenter Study of 4-Chloro-m-cresol for Diagnosing Malignant Hyperthermia Susceptibility.
C. P. Baur, L. Bellon, P. Felleiter, M. Fiege, R. Fricker, K. Glahn, J. J. A. Heffron, A. Herrmann-Frank, K. Jurkat-Rott, W. Klingler, et al. (2000)
Anesth. Analg. 90, 200
   Abstract »    Full Text »    PDF »
A Postulated Role of the Near Amino-terminal Domain of the Ryanodine Receptor in the Regulation of the Sarcoplasmic Reticulum Ca2+ Channel.
R. El-Hayek, Y. Saiki, T. Yamamoto, and N. Ikemoto (1999)
J. Biol. Chem. 274, 33341-33347
   Abstract »    Full Text »    PDF »
Suramin and Suramin Analogs Activate Skeletal Muscle Ryanodine Receptor via a Calmodulin Binding Site.
M. Klinger, M. Freissmuth, P. Nickel, M. Stäbler-Schwarzbart, M. Kassack, J. Suko, and M. Hohenegger (1999)
Mol. Pharmacol. 55, 462-472
   Abstract »    Full Text »
Modification of excitation-contraction coupling by 4-chloro-m-cresol in voltage-clamped cut muscle fibres of the frog (R. pipiens).
A Struk and W Melzer (1999)
J. Physiol. 515, 221-231
   Abstract »    Full Text »    PDF »
Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
V. Barone, O. Massa, E. Intravaia, A. Bracco, A. Di Martino, V. Tegazzin, S. Cozzolino, and V. Sorrentino (1999)
J. Med. Genet. 36, 115-118
   Abstract »    Full Text »
Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release Channels.
J. Tong, T. V. McCarthy, and D. H. MacLennan (1999)
J. Biol. Chem. 274, 693-702
   Abstract »    Full Text »    PDF »
The Cytoplasmic Loops between Domains II and III and Domains III and IV in the Skeletal Muscle Dihydropyridine Receptor Bind to a Contiguous Site in the Skeletal Muscle Ryanodine Receptor.
P. Leong and D. H. MacLennan (1998)
J. Biol. Chem. 273, 29958-29964
   Abstract »    Full Text »    PDF »
A 37-Amino Acid Sequence in the Skeletal Muscle Ryanodine Receptor Interacts with the Cytoplasmic Loop between Domains II and III in the Skeletal Muscle Dihydropyridine Receptor.
P. Leong and D. H. MacLennan (1998)
J. Biol. Chem. 273, 7791-7794
   Abstract »    Full Text »    PDF »
Prolonged exposure to halothane and associated changes in carbohydrate metabolism in rat muscles in vivo.
L. D. M. C.-B. Ferreira, T. N. Palmer, and P. A. Fournier (1998)
J Appl Physiol 84, 1470-1474
   Abstract »    Full Text »    PDF »
Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core Disease.
J. Tong, H. Oyamada, N. Demaurex, S. Grinstein, T. V. McCarthy, and D. H. MacLennan (1997)
J. Biol. Chem. 272, 26332-26339
   Abstract »    Full Text »    PDF »
Anesthesiology- First of Two Parts.
R. A. Wiklund and S. H. Rosenbaum (1997)
N. Engl. J. Med. 337, 1132-1141
   Full Text »    PDF »
Ion Channels -- Molecular Divining Rods Hit Their Clinical Mark.
E. P. Hoffman and K. Gardner (1997)
N. Engl. J. Med. 336, 1599-1600
   Full Text »
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States.
R. Zucchi and S. Ronca-Testoni (1997)
Pharmacol. Rev. 49, 1-52
   Abstract »    Full Text »    PDF »
Mouse models of human disease. Part II: recent progress and future directions..
M A Bedell, D A Largaespada, N A Jenkins, and N G Copeland (1997)
Genes & Dev. 11, 11-43
   PDF »
Mutational Analysis of the Ligand Binding Site of the Inositol 1,4,5-Trisphosphate Receptor.
F. Yoshikawa, M. Morita, T. Monkawa, T. Michikawa, T. Furuichi, and K. Mikoshiba (1996)
J. Biol. Chem. 271, 18277-18284
   Abstract »    Full Text »    PDF »
Regulation of Tissue-specific Expression of the Skeletal Muscle Ryanodine Receptor Gene.
S. Schmoelzl, T. Leeb, H. Brinkmeier, G. Brem, and B. Brenig (1996)
J. Biol. Chem. 271, 4763-4769
   Abstract »    Full Text »    PDF »
Identification of Dantrolene Binding Sites in Porcine Skeletal Muscle Sarcoplasmic Reticulum.
J. Parness and S. S. Palnitkar (1995)
J. Biol. Chem. 270, 18465-18472
   Abstract »    Full Text »    PDF »
Pharmacogenetics: Its Place in Medicine and Biology.
W. Kalow (1992)
Journal of Pharmacy Practice 5, 312-316
   Abstract »    PDF »
Molecular Cloning, Expression, Functional Characterization, Chromosomal Localization, and Gene Structure of Junctate, a Novel Integral Calcium Binding Protein of Sarco(endo)plasmic Reticulum Membrane.
S. Treves, G. Feriotto, L. Moccagatta, R. Gambari, and F. Zorzato (2000)
J. Biol. Chem. 275, 39555-39568
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)